483
Maria Alora Palli, M.D.FDA 483 - Maria Alora Palli, M.D. - April 29, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS) in Boston, MA, revealed a significant issue regarding adherence to investigational plans. The firm failed to conduct an investigation in accordance with its protocol, specifically concerning the administration of instructions to study subjects. This indicates a deviation from established clinical trial procedures.
Open in Dashboard
ID · 1f774ec4-87d5-4cf7-816e-118e6e284571